October 28 & 29 by Zoom: We are happy to announce the 1^st Professor Edgar Housepian Clinical Neuroscience Virtual Symposium on Epilepsy. This is a special event for ICPD and especially for ARABKIR Medical Center to pay tribute to Dr. Housepian, organizing the first of the series to come. You can find detailed information by Clicking here

Boston University is refuting a series of misleading claims about research at the University’s National Emerging Infectious Diseases Laboratories (NEIDL), shown at right. The reports, which first appeared Oct. 17 in the United Kingdom’s Daily Mail, claimed researchers at the lab had “created a new deadly COVID strain.” In a statement Oct. 17, BU called the reporting, which was picked up by other outlets, including Fox News, “false and inaccurate,” and said this research made the virus less dangerous.

The University also noted that the research was reviewed and approved by the Institutional Biosafety Committee (IBC), which consists of scientists as well as local community members, and that the Boston Public Health Commission had approved the research.

“They’ve sensationalized the message, they misrepresent the study and its goals in its entirety,” says Ronald B. Corley, NEIDL director and BU Chobanian & Avedisian School of Medicine chair of microbiology, of the news reports.

Read entire article

Congratulations to Ani Nalbandian, MD for receiving the Glorney-Raisbeck Fellowship Award in Cardiovascular Diseases at The New York Academy of Medicine, funding her original clinical research trial entitled "Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy." Dr. Nalbandian is a cardiology fellow at Columbia University Irving Medical Center-New York Presbyterian Hospital. She is also completing a Master's degree in Patient Oriented Research at Columbia University Mailman School of Public Health.